School of Medicine
Showing 21-30 of 30 Results
-
Tauhid (Md Tauhidul) Islam
Assistant Professor of Radiation Oncology (Radiation Physics)
Current Research and Scholarly InterestsMy research focuses on developing computationally efficient and clinically reliable AI methods for biomedical imaging and high-dimensional molecular data, with an emphasis on cancer and neurological disease. The Islam Lab designs novel representations and learning frameworks that improve deep learning performance in data-constrained biomedical settings, including methods that transform tabular omics data into spatially meaningful representations.
-
Haruka Itakura, MD, PhD
Assistant Professor of Medicine (Oncology)
BioDr. Haruka Itakura is an Assistant Professor of Medicine (Oncology) in the Stanford University School of Medicine, a data scientist, and a practicing breast medical oncologist at the Stanford Women’s Cancer Center. She is board-certified in Oncology, Clinical Informatics, Hematology, and Internal Medicine. Her research mission is to drive medical advances at the intersection of cancer and data science, applying state-of-the-art machine learning/artificial intelligence (AI) techniques to extract clinically actionable knowledge from heterogeneous multi-scale cancer data to improve patient outcomes. Her ongoing research to develop robust methodologies and apply cutting-edge techniques to analyze complex cancer big data was catapulted by an NIH K01 Career Development Award in Biomedical Big Data Science after obtaining a PhD in Biomedical Informatics at Stanford University. Her cancer research focuses on extracting radiomic (pixel-level quantitative imaging) features of tumors from medical imaging studies and applying machine learning frameworks, including radiogenomic approaches, for the integrative analysis of heterogeneous, multiomic (e.g., radiomic, genomic, transcriptomic) data to accelerate discoveries in cancer diagnostics and therapeutics. Her current projects include data science/AI-powered prediction modeling of survival, treatment response, cancer recurrence, and metastasis in different cancer subtypes; detection of occult invasive breast cancer; and identification of novel therapeutic targets. Her goal is to translate her research findings back to the clinical setting for the benefit of patients with difficult-to-treat cancers.
-
Reem Itani, MD, MACM
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Itani is board certified in general pediatrics, and board eligible in pediatric pulmonology and sleep medicine. She is fellowship trained in pediatric pulmonology and sleep medicine.
Dr. Itani diagnoses and treats a wide range of sleep disorders in adults and children.
Dr. Itani’s research interests include medical education and patient compliance and education. Her other research interests have included sleep consequences of Prader-Willi syndrome and congenital central hypoventilation syndrome.
Dr. Itani has published her research in peer-reviewed journals including Journal of Clinical Sleep Medicine, Current Neurology and Neuroscience Reports, Medical Teacher, and Brain & Development. She has presented to her peers at national and regional meetings, including the Institute for Healthcare Improvement, the Innovations in Medical Education Conference, and the American Thoracic Society.
Dr. Itani is a fellow of the American Academy of Pediatrics and a member of the American Thoracic Society and the American College of Chest Physician. -
Michael Iv
Clinical Professor, Radiology
Current Research and Scholarly InterestsMy clinical and research interests include brain tumor and vascular imaging in both the adult and pediatric populations, incorporating advanced MR imaging techniques and analyses using qualitative and quantitative methods.
-
Rebecca Ivancie
Clinical Associate Professor, Pediatrics
Current Research and Scholarly InterestsMedical Education Projects
- PHM Fellows and their training in Community Pediatric Hospital Medicine
Clinical Research: Using PHIS database to study MIS-C and Kawasaki disease -
Fabio Iwamoto, MD
Professor of Neurology and Neurological Sciences (Adult Neurology) and of Neurosurgery (Adult Neurosurgery)
BioDr. Fabio Iwamoto is a board-certified, fellowship-trained neuro-oncologist at Stanford Health Care. He is also a professor in the Department of Neurology & Neurological Sciences, Division of Neuro-Oncology, and a professor of neurosurgery in the Department of Neurosurgery, Division of Neurosurgical Oncology at Stanford University School of Medicine.
Dr. Iwamoto cares for brain and spinal cord tumors, guiding patients from diagnosis through treatment and follow-up. He specializes in managing cancer that has spread to the brain or spinal cord, working with multiple specialists to develop individualized treatment plans. He also has expertise treating tumors called gliomas, including glioblastomas. Throughout the patient journey, Dr. Iwamoto addresses cancer-related complications, such as cancer therapy side effects, numbness, and memory problems. He strives to deliver the highest level of compassionate, patient-centered care, supporting patients and families through complex decisions and challenging moments.
Dr. Iwamoto’s research focuses on developing and evaluating innovative treatments for brain tumors, particularly gliomas and glioblastomas. He studies immunotherapies, targeted therapies, and novel therapy combinations to improve tumor treatment. He leads several national and international clinical trials with the goal of bringing promising discoveries from the laboratory to patients.
Dr. Iwamoto has authored many publications in leading journals, including Nature Cancer, Nature Medicine, Neuro-Oncology, and the Journal of Clinical Oncology. He has published several book chapters on key topics in neuro-oncology, including emerging glioma treatments and the diagnosis and management of central nervous system tumors. He has also shared his expertise and research findings around the world at meetings of the American Society of Clinical Oncology, American Association for Cancer Research, and international neuro-oncology forums.
